Form 4 for RCUS Arcus Biosciences, Inc.
Accepted 2026-01-02 00:00:00 ET · period of report 2025-12-31 · accession 0001610717-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-01-02 | 2025-12-31 | RCUS | Goeltz II Robert C. | CFO | S - Sale | $23.38 | -6,552 | 67.9K | -9% | -$153.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-31 | S | D | 6,552 | $23.38 | 67,924 | D | — | — |